Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study

Autor: Falcon-Neyra L, Palladino C, Navarro Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Frick MA, Fortuny-Guasch C, Noguera-Julián A, Moreno EB, Santos JL, Olbrich P, López-Cortés LF, Briz V, Neth O, CoRISpe working group

Publikováno v: Medicine
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

To assess the safety and efficacy of rilpivirine in combination with emtricitabine and tenofovir (RPV/FTC/TDF) as a once-daily single-tablet regimen (STR) in HIV-1-infected children and adolescents we performed a multicenter case series study of HIV-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::48d0a8c83e1bb7c1ce61887e75fe0afb
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11270

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Structural and thermodynamic consequences of burial of an artificial ion pair in the hydrophobic interior of a protein.

Autor: Robinson AC; Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; and., Castañeda CA; Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; and., Schlessman JL; Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; andChemistry Department, United States Naval Academy, Annapolis, MD 21402., García-Moreno EB; Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; and bertrand@jhu.edu.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2014 Aug 12; Vol. 111 (32), pp. 11685-90. Date of Electronic Publication: 2014 Jul 29.